Neutra Corp.

NTRR

US64129C3034

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 15:14:35 2024-05-16 EDT			5-day change	1st Jan Change
0.0004 ^USD	+33.33%		+33.33%	+33.33%

2023	Neutra Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	CI
2023	Neutra Corp. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	CI

Neutra Corp. Reports Earnings Results for the First Quarter Ended April 30, 2019

June 14, 2019 at 04:04 pm

Neutra Corp. announced earnings results for the first quarter ended April 30, 2019. For the first quarter, the company announced operating loss was USD 66,951 compared to USD 63,852 a year ago. Net loss was USD 128,212 compared to USD 131,844 a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.02 a year ago.

Latest news about Neutra Corp.

Neutra Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	12-15	CI
Neutra Corp. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	23-09-14	CI
Neutra Corp. Reports Earnings Results for the First Quarter Ended April 30, 2023	23-06-22	CI
Neutra Corp. Reports Earnings Results for the Full Year Ended January 31, 2023	23-06-09	CI
Neutra Corp. Auditor Raises 'Going Concern' Doubt	23-06-08	CI
Neutra Corp. executed a binding letter of intent to acquire Mercury Clinical Research, Inc.	23-01-29	CI
Neutra Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022	22-12-15	CI
Neutra Corp. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022	22-09-14	CI
Neutra Corp. Reports Earnings Results for the First Quarter Ended April 30, 2022	22-06-21	CI
Neutra Corp. Reports Earnings Results for the Full Year Ended January 31, 2022	22-05-10	CI
Neutra Corp. Auditor Raises 'Going Concern' Doubt	22-05-09	CI
Neutra Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2021	21-12-10	CI
Neutra Corp. Reports Earnings Results for the Second Quarter Ended July 31, 2021	21-09-14	CI
Neutra Corp. acquired Deity Wellness.	21-06-22	CI
Neutra Corp. Reports Earnings Results for the First Quarter Ended April 30, 2021	21-06-21	CI
Neutra Corp. Reports Earnings Results for the Third Quarter Ended October 31, 2020	20-12-21	CI
Neutra Corp. Reports Earnings Results for the Second Quarter Ended July 31, 2020	20-09-14	CI
Neutra Corp. Reports Earnings Results for the First Quarter Ended April 30, 2020	20-07-14	CI
Neutra Corp.'s VIVIS Introduces three New Products into the CBD Marketplace	20-07-02	CI
Neutra Corp. announced that it has received funding	19-12-31	CI
Neutra Corp. Reports Earnings Results for the Third Quarter Ended October 31, 2019	19-12-23	CI
Neutra Corp. Reports Earnings Results for the Second Quarter Ended July 31, 2019	19-09-23	CI
Neutra Corp. completed the acquisition of Vivis Corporation from Sydney Jim and others.	19-09-09	CI
Neutra Corp. entered into letter of intent to acquire Vivis Corporation from Sydney Jim and others for $0.04 million.	19-07-25	CI
Neutra Corp. Reports Earnings Results for the First Quarter Ended April 30, 2019	19-06-14	CI

Chart Neutra Corp.

Duration

Period

More charts

Company Profile

Neutra Corp. is an early-stage research and development company. The Company is engaged in marketing and participating in the nutraceutical space by bringing products derived from all natural and organic origins. The Company plans to research and bring new technology to the Nutraceutical space. The Company is primarily focused on participating in the medical cannabis market, which is a nutraceutical sub-market. It intends to entrust the manufacturing to a nutraceutical contractor to private label all of its products and to sell them under its brand. It primarily sells hemp-derived products, including products containing delta-8-THC and other cannabinoids. Its subsidiaries include Diamond Anvil Designs, LLC, Deity Corporation and Vivis Corporation.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
NEUTRA CORP.	+33.33%	875K
ELI LILLY AND COMPANY	+32.36%	709B
NOVO NORDISK A/S	+30.77%	595B
JOHNSON & JOHNSON	-1.60%	367B
MERCK & CO., INC.	+20.07%	334B
ABBVIE INC.	+6.04%	289B
ASTRAZENECA PLC	+14.77%	239B
NOVARTIS AG	+9.13%	211B
ROCHE HOLDING AG	-3.97%	203B
AMGEN INC.	+9.27%	171B

Other Pharmaceuticals

Neutra Corp.

Equities

NTRR

US64129C3034

Pharmaceuticals

Neutra Corp. Reports Earnings Results for the First Quarter Ended April 30, 2019

Latest news about Neutra Corp.

Chart Neutra Corp.

Company Profile

Income Statement Evolution

Sector Other Pharmaceuticals